E
Evrofarma SA
ATHEX:EVROF
Evrofarma SA
ATHEX:EVROF
Price:
3.52
EUR
0.57%
Market Closed
Market Cap:
€48.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
E
|
Evrofarma SA
ATHEX:EVROF
|
GR |
|
Ops Ecom SpA
MIL:OEC
|
IT |
|
C
|
CelcomDigi Bhd
KLSE:CDB
|
MY |
|
Pharmanutra SpA
MIL:PHN
|
IT |
|
SOPerior Fertilizer Corp
OTC:POTRF
|
CA |
|
Akcansa Cimento Sanayi ve Ticaret AS
IST:AKCNS.E
|
TR |
|
Mill City Ventures III Ltd
NASDAQ:MCVT
|
US |
|
H
|
Huhtamaki Oyj
OMXH:HUH1V
|
FI |
|
AltC Acquisition Corp
NYSE:OKLO
|
US |
|
P
|
Polygon Real Estate Ltd
TASE:POLY
|
IL |
|
O
|
Ourpalm Co Ltd
SZSE:300315
|
CN |
|
Target Hospitality Corp
NASDAQ:TH
|
US |
|
Visiomed Group SA
PAR:ALVMG
|
FR |
|
Y
|
Youngchang Chemical Co Ltd
KOSDAQ:112290
|
KR |
|
Bharat Bijlee Ltd
NSE:BBL
|
IN |
|
A
|
Activision Blizzard Inc
LSE:0H8X
|
US |
|
B
|
Bertam Alliance Bhd
KLSE:BERTAM
|
MY |
|
Ginting Jaya Energi Tbk PT
IDX:WOWS
|
ID |
|
Europap Tezol Kagit Sanayi Ve Ticaret AS
IST:TEZOL.E
|
TR |
|
EVgo Inc
NASDAQ:EVGO
|
US |
|
P
|
PIK Spetsializirovannyi Zastroyshchik PAO
MOEX:PIKK
|
RU |
|
J
|
Jiangsu Sidike New Materials Science & Technology Co Ltd
SZSE:300806
|
CN |
|
China Zhonghua Geotechnical Engineering Group Co Ltd
SZSE:002542
|
CN |
|
Cboe Global Markets Inc
F:C67
|
US |
Balance Sheet
Balance Sheet Decomposition
Evrofarma SA
Evrofarma SA
Balance Sheet Decomposition is not available for
Evrofarma SA
Evrofarma SA
Balance Sheet
Evrofarma SA
Evrofarma SA
Currency: EUR
| Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||||||
| Cash & Cash Equivalents |
4
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
3
|
0
|
1
|
1
|
3
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
4
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
3
|
0
|
1
|
1
|
3
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
9
|
9
|
11
|
9
|
9
|
12
|
15
|
13
|
12
|
10
|
8
|
10
|
10
|
10
|
11
|
12
|
12
|
10
|
12
|
14
|
12
|
9
|
7
|
|
| Accounts Receivables |
5
|
6
|
5
|
8
|
6
|
10
|
13
|
11
|
11
|
9
|
6
|
8
|
10
|
10
|
11
|
12
|
12
|
10
|
12
|
14
|
12
|
9
|
7
|
|
| Other Receivables |
4
|
4
|
5
|
1
|
3
|
1
|
2
|
2
|
1
|
1
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
7
|
5
|
5
|
3
|
4
|
5
|
4
|
5
|
5
|
3
|
2
|
2
|
4
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
5
|
6
|
7
|
|
| Other Current Assets |
2
|
3
|
2
|
2
|
2
|
2
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
21
|
18
|
18
|
14
|
15
|
20
|
20
|
18
|
18
|
13
|
12
|
12
|
14
|
14
|
15
|
17
|
16
|
13
|
19
|
17
|
19
|
16
|
18
|
|
| PP&E Net |
17
|
18
|
25
|
26
|
26
|
27
|
31
|
34
|
37
|
35
|
35
|
32
|
31
|
29
|
28
|
27
|
27
|
27
|
27
|
29
|
29
|
30
|
30
|
|
| PP&E Gross |
17
|
18
|
25
|
26
|
26
|
27
|
31
|
34
|
37
|
35
|
35
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
7
|
8
|
9
|
11
|
13
|
15
|
16
|
17
|
19
|
20
|
23
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
3
|
3
|
3
|
2
|
3
|
3
|
2
|
2
|
2
|
3
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Other Long-Term Assets |
4
|
4
|
1
|
0
|
1
|
1
|
0
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
45
N/A
|
42
-6%
|
47
+13%
|
42
-10%
|
45
+6%
|
51
+13%
|
53
+5%
|
55
+4%
|
58
+4%
|
53
-8%
|
49
-8%
|
47
-4%
|
47
+1%
|
44
-6%
|
44
-1%
|
45
+3%
|
44
-2%
|
41
-7%
|
46
+13%
|
47
+0%
|
49
+5%
|
47
-3%
|
48
+2%
|
|
| Liabilities | ||||||||||||||||||||||||
| Accounts Payable |
1
|
2
|
1
|
4
|
5
|
7
|
4
|
8
|
5
|
4
|
5
|
7
|
8
|
6
|
6
|
8
|
8
|
5
|
7
|
7
|
7
|
6
|
6
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
2
|
1
|
2
|
0
|
0
|
0
|
3
|
0
|
5
|
4
|
24
|
0
|
0
|
0
|
0
|
7
|
6
|
8
|
1
|
1
|
2
|
4
|
10
|
|
| Current Portion of Long-Term Debt |
4
|
4
|
3
|
8
|
10
|
7
|
10
|
14
|
12
|
15
|
0
|
9
|
7
|
7
|
9
|
11
|
2
|
9
|
3
|
3
|
3
|
3
|
2
|
|
| Other Current Liabilities |
1
|
1
|
2
|
0
|
1
|
1
|
1
|
0
|
2
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
8
|
8
|
8
|
13
|
15
|
15
|
17
|
22
|
23
|
24
|
31
|
16
|
15
|
13
|
15
|
26
|
16
|
22
|
11
|
10
|
13
|
13
|
18
|
|
| Long-Term Debt |
19
|
18
|
16
|
10
|
9
|
15
|
15
|
12
|
13
|
10
|
1
|
14
|
16
|
15
|
11
|
1
|
10
|
1
|
17
|
18
|
16
|
13
|
5
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Minority Interest |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
3
|
5
|
5
|
5
|
5
|
6
|
6
|
7
|
6
|
7
|
6
|
6
|
6
|
6
|
5
|
5
|
4
|
5
|
5
|
6
|
|
| Total Liabilities |
29
N/A
|
26
-9%
|
23
-11%
|
26
+10%
|
29
+13%
|
35
+19%
|
37
+8%
|
40
+6%
|
42
+6%
|
40
-5%
|
39
-3%
|
37
-4%
|
38
+3%
|
35
-9%
|
34
-3%
|
34
+2%
|
33
-5%
|
29
-10%
|
33
+14%
|
34
+1%
|
35
+3%
|
31
-11%
|
30
-2%
|
|
| Equity | ||||||||||||||||||||||||
| Common Stock |
8
|
8
|
10
|
10
|
10
|
10
|
10
|
10
|
12
|
12
|
12
|
12
|
12
|
12
|
12
|
12
|
12
|
12
|
12
|
12
|
12
|
6
|
6
|
|
| Retained Earnings |
5
|
4
|
5
|
6
|
5
|
5
|
5
|
5
|
3
|
0
|
3
|
3
|
4
|
3
|
3
|
2
|
1
|
1
|
0
|
0
|
1
|
10
|
12
|
|
| Additional Paid In Capital |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
|
| Other Equity |
2
|
2
|
7
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
16
N/A
|
16
-1%
|
24
+52%
|
17
-30%
|
16
-6%
|
16
+2%
|
16
0%
|
16
-2%
|
16
+0%
|
13
-19%
|
10
-21%
|
10
-4%
|
9
-4%
|
10
+6%
|
10
+4%
|
11
+5%
|
12
+9%
|
12
+2%
|
13
+9%
|
13
-3%
|
14
+11%
|
16
+16%
|
18
+10%
|
|
| Total Liabilities & Equity |
45
N/A
|
42
-6%
|
47
+13%
|
42
-10%
|
45
+6%
|
51
+13%
|
53
+5%
|
55
+4%
|
58
+4%
|
53
-8%
|
49
-8%
|
47
-4%
|
47
+1%
|
44
-6%
|
44
-1%
|
45
+3%
|
44
-2%
|
41
-7%
|
46
+13%
|
47
+0%
|
49
+5%
|
47
-3%
|
48
+2%
|
|
| Shares Outstanding | ||||||||||||||||||||||||
| Common Shares Outstanding |
14
|
14
|
14
|
14
|
14
|
14
|
14
|
14
|
14
|
14
|
14
|
14
|
14
|
14
|
14
|
14
|
14
|
14
|
14
|
14
|
14
|
14
|
14
|
|
Switch to:
Switch to:
See Also
Discover More
